From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors

RL Wahl, H Jacene, Y Kasamon… - Journal of nuclear …, 2009 - Soc Nuclear Med
The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

[PDF][PDF] American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline: Update 2003

DG Pfister, DH Johnson, CG Azzoli… - Journal of Clinical …, 2004 - spitalmures.ro
The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

GJ Kelloff, JM Hoffman, B Johnson, HI Scher… - Clinical Cancer …, 2005 - AACR
[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

18F-FDG PET/CT Imaging In Oncology

A Almuhaideb, N Papathanasiou… - Annals of Saudi …, 2011 - annsaudimed.net
Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …

Lung cancer surveillance after definitive curative-intent therapy: ASCO guideline

BJ Schneider, N Ismaila, J Aerts, C Chiles… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide evidence-based recommendations to practicing clinicians on
radiographic imaging and biomarker surveillance strategies after definitive curative-intent …

Metabolic positron emission tomography imaging in cancer detection and therapy response

A Zhu, D Lee, H Shim - Seminars in oncology, 2011 - Elsevier
Positron emission tomography (PET) is a noninvasive imaging technique that provides a
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …

Clinical role of FDG PET in evaluation of cancer patients

L Kostakoglu, H Agress Jr, SJ Goldsmith - Radiographics, 2003 - pubs.rsna.org
Positron emission tomography (PET) is a diagnostic imaging technique that allows
identification of biochemical and physiologic alterations in tumors. Use of PET performed …

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients …

MP Mac Manus, RJ Hicks, JP Matthews… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To prospectively study the capacity of positron emission tomography (PET) and
computed tomography (CT) to determine response soon after radical radiotherapy or …

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non–small cell lung cancer

HHW Chen, NT Chiu, WC Su, HR Guo, BF Lee - Radiology, 2012 - pubs.rsna.org
Purpose To determine whether whole-body total lesion glycolysis (TLG), which combines
volumetric and metabolic information from fluorine 18 fluorodeoxyglucose (FDG) positron …

[HTML][HTML] EANM/EARL FDG-PET/CT accreditation-summary results from the first 200 accredited imaging systems

A Kaalep, T Sera, W Oyen, BJ Krause, A Chiti… - European journal of …, 2018 - Springer
Abstract Purpose From 2010 until July 2016, the EANM Research Ltd.(EARL) FDG-PET/CT
accreditation program has collected over 2500 phantom datasets from approximately 200 …